Literature DB >> 24877196

Subcutaneous histiocytoid Sweet's syndrome in a patient with myelodysplastic syndrome and acute myeloblastic leukemia.

Chutika Srisuttiyakorn, Jennifer Reeve, Swapna Reddy, Suguru Imaeda, Rossitza Lazova.   

Abstract

Subcutaneous histiocytoid Sweet’s syndrome is a rare variant of histiocytoid Sweet’s syndrome (SS). We present a 68-year-old woman with subcutaneous histiocytoid SS in association with refractory myelodysplastic syndrome transformed to acute myeloblastic leukemia (AML), status post induction chemotherapy and with persistent blasts (50%) in the bone marrow and blood, accompanied with neutropenia. The patient presented to the emergency room with fever and altered mental status. Clinical examination revealed approximately 20 scattered 0.5-2 cm, pink to pink-purple non-tender firm nodules on the legs and left arm. The differential diagnosis included Sweet’s syndrome (deep), leukemia cutis, infection, polyarteritis nodosa and erythema nodosum. Histopathologic examination of a biopsy from the left arm revealed a nodular infiltrate of neutrophils and histiocytoid mononuclear cells solely in the lobular compartment of the subcutaneous fat with focal areas of necrosis. Most cells in the infiltrate labeled with myeloperoxidase (MPO) including the histiocytoid cells. The cells were negative for CD34 and CD117. All special stains for microorganisms were negative. A diagnosis of subcutaneous histiocytoid SS was made. A subcutaneous histiocytoid SS should be suspected when a neutrophilic/histiocytoid panniculitis, occurring in the setting of myeloid disorders, is encountered and after exclusion of an infectious process and leukemia cutis.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24877196     DOI: 10.1111/cup.12305

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  6 in total

1.  Clinicopathologic, Immunohistochemical, and Molecular Features of Histiocytoid Sweet Syndrome.

Authors:  Victoria Alegría-Landa; Socorro María Rodríguez-Pinilla; Angel Santos-Briz; José Luis Rodríguez-Peralto; Victor Alegre; Lorenzo Cerroni; Heinz Kutzner; Luis Requena
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

2.  Histiocytoid Sweet Syndrome Is More Frequently Associated With Myelodysplastic Syndromes Than the Classical Neutrophilic Variant: A Comparative Series of 62 Patients.

Authors:  Lisa Ghoufi; Nicolas Ortonne; Saskia Ingen-Housz-Oro; Walid Barhoumi; Edouard Begon; Corinne Haioun; Cécile Pautas; Florence Beckerich; Christine Robin; Pierre Wolkenstein; Catherine Cordonnier; Olivier Chosidow; Andréa Toma
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 3.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

4.  Acute myeloid leukemia with adult atopic dermatitis as first manifestation: A case report.

Authors:  Wei-Wei Ma; Lorna Martin Kasyanju Carrero; Xu-Feng Yin; Hou-Fang Liu; Bing-Rong Zhou
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Histiocytoid Sweet's syndrome in a patient with myelodsyplastic syndrome: report and review of the literature.

Authors:  Michael M Shalaby; Ryan R Riahi; Les B Rosen; Erik J Soine
Journal:  Dermatol Pract Concept       Date:  2016-01-31

6.  Histiocytoid Sweet Syndrome in a Child without Underlying Systemic Disease.

Authors:  Seung Dohn Yeom; Hye Soo Ko; Jong Hyuk Moon; Min Ji Kang; Ji Won Byun; Gwang Seong Choi; Jeonghyun Shin
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.